Yesterday evening, RxSight released preliminary revenue results for the three ... who can usually delay procedures indefinitely by continuing to wear their glasses or contact lenses. However, a ...

I have confidently helped patients navigate the IOL selection process for both cataract surgery and refractive lens ...

ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...

All you have to do is check in with the names that define the category today, the brands that focus on eyewear not as an ancillary element of their business, but as their entire raison d'être.

Shares of RxSight, Inc. (NASDAQ:RXST – Get Free Report) hit a new 52-week low on Thursday after Bank of America lowered their price target on the stock from $60.00 to $36.00. Bank of America ...

RxSight stock opened at $24.90 on Wednesday. The firm has a market capitalization of $1.01 billion, a P/E ratio of -30.00 and a beta of 1.22. RxSight has a 1 year low of $24.38 and a 1 year high ...

9 analysts have expressed a variety of opinions on RxSight (NASDAQ:RXST) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

Smart glasses have transitioned from experimental gadgets to essential wearables that blend artificial intelligence (AI) and augmented reality (AR). The latest models offer immersive experiences, ...